2DI

9-[(2R,5R)-5-(HYDROXYMETHYL)TETRAHYDROFURAN-2-YL]-1,9-DIHYDRO-6H-PURIN-6-ONE

Created: 2003-11-11
Last modified:  2020-06-05

Find related ligands:

Chemical Details

Formal Charge0
Atom Count29
Chiral Atom Count2
Bond Count31
Aromatic Bond Count5
2D diagram of 2DI

Chemical Component Summary

Name9-[(2R,5R)-5-(HYDROXYMETHYL)TETRAHYDROFURAN-2-YL]-1,9-DIHYDRO-6H-PURIN-6-ONE
Synonyms2',3'-DIDEOXYINOSINE; Didanosine
Systematic Name (OpenEye OEToolkits)9-[(2R,5S)-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one
FormulaC10 H12 N4 O3
Molecular Weight236.227
TypeNON-POLYMER

Chemical Descriptors

TypeProgram Version Descriptor
SMILESACDLabs12.01O=C1c2ncn(c2N=CN1)C3OC(CC3)CO
SMILESCACTVS3.370OC[CH]1CC[CH](O1)n2cnc3C(=O)NC=Nc23
SMILESOpenEye OEToolkits1.7.6c1nc2c(n1C3CCC(O3)CO)N=CNC2=O
Canonical SMILESCACTVS3.370 OC[C@@H]1CC[C@@H](O1)n2cnc3C(=O)NC=Nc23
Canonical SMILESOpenEye OEToolkits1.7.6 c1nc2c(n1[C@H]3CC[C@H](O3)CO)N=CNC2=O
InChIInChI1.03 InChI=1S/C10H12N4O3/c15-3-6-1-2-7(17-6)14-5-13-8-9(14)11-4-12-10(8)16/h4-7,15H,1-3H2,(H,11,12,16)/t6-,7+/m0/s1
InChIKeyInChI1.03 BXZVVICBKDXVGW-NKWVEPMBSA-N

Drug Info: DrugBank

DrugBank IDDB00900 
NameDidanosine
Groups approved
DescriptionA dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by a hydrogen. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. Didanosine is a potent inhibitor of HIV replication, acting as a chain-terminator of viral DNA by binding to reverse transcriptase; ddI is then metabolized to dideoxyadenosine triphosphate, its putative active metabolite.
Synonyms
  • 9-((2S,5R)-5-Hydroxymethyl-tetrahydro-furan-2-yl)-9H-purin-6-ol
  • Didanosinum
  • Didanosina
  • 9-((2R,5S)-5-(hydroxymethyl)-tetrahydrofuran-2-yl)-1H-purin-6(9H)-one
  • 9-[(2R,5S)-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1,9-dihydro-6H-purin-6-one
Brand Names
  • Videx EC
  • Videx Chewable Dispersible Tab 100mg
  • Videx Chewable Dispersible Tab 150mg
  • Videx Chewable Dispersible Tab 50mg
  • Didanosine
IndicationFor use, in combination with other antiretroviral agents, in the treatment of HIV-1 infection in adults.
Categories
  • Anti-HIV Agents
  • Anti-Infective Agents
  • Anti-Retroviral Agents
  • Antiinfectives for Systemic Use
  • Antimetabolites
ATC-CodeJ05AF02
CAS number69655-05-6

Drug Targets

NameTarget SequencePharmacological ActionActions
Reverse transcriptase/RNaseHPISPIETVPVKLKPGMDGPKVKQWPLTEEKIKALVEICTEMEKEGKISKI...unknowninhibitor
Gag-Pol polyproteinMGARASVLSGGELDRWEKIRLRPGGKKKYKLKHIVWASRELERFAVNPGL...unknowninhibitor
Purine nucleoside phosphorylaseMENGYTYEDYKNTAEWLLSHTKHRPQVAIICGSGLGGLTDKLTQAQIFDY...unknownsubstrate
AlbuminMKWVTFISLLFLFSSAYSRGVFRRDAHKSEVAHRFKDLGEENFKALVLIA...unknown
Solute carrier family 22 member 6MAFNDLLQQVGGVGRFQQIQVTLVVLPLLLMASHNTLQNFTAAIPTHHCR...unknownsubstrate
View More
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
PubChem 50599, 135398739, 5273537
ChEMBL CHEMBL1460
ChEBI CHEBI:490877
CCDC/CSD CUYDOQ